S
009300
vs
JNJ
JNJ
Over the past 12 months, Sam-A Pharm Co Ltd has underperformed JNJ, delivering a return of +1% compared to the JNJ's +49% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
JNJ
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd
KOSDAQ:009300
|
16 570
KRW
|
|||||
|
Johnson & Johnson
NYSE:JNJ
|
234.54
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
009300, JNJ
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Sam-A Pharm Co Ltd
Revenue
|
|||||||||||
|
Johnson & Johnson
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
009300, JNJ
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Sam-A Pharm Co Ltd
KOSDAQ:009300
|
|||||||||
|
Johnson & Johnson
NYSE:JNJ
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd | ||||
|
Johnson & Johnson | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
009300, JNJ
Performance By Year
009300, JNJ
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|